An observational study in Aging, sponsored by Barcelonabeta Brain Research Center, Pasqual Maragall Foundation. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-06-09.
Sponsored by Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Observational
Ageing is clearly the most important risk factor for AD and other dementias but, despite the amount of evidence supporting this fact, the exact mechanism that link ageing and AD is still unknown and, up to now, potential therapies for AD by targeting ageing have been poorly explored. This study aims to provide a better understanding of the link between ageing and AD by means of measuring in human blood those factors that have been found to be 'pro-youthful' (GDF-11, CSF2, TIMP-2, oxytocin) or 'pro-aging' (CCL2, CCL11, CCL19, Haptoglobine, B2-microglobuline) in experimental animal models, but have not been comprehensively studied in humans.
In this proof-of-concept study these blood factors in extreme groups of age, namely young adults (18-25 yo) and old adults (≥70 yo) will be measured and the hypothesis of whether the 'pro-youthful' and 'pro-ageing' blood factors change throughout age tested. In order to include a wider range of age, human umbilical cord blood and plasma from teenagers (which is already available from a previous study) will also be included.
The ultimate goal of this study is to select the more promising blood factors and obtain data on the effect size of the differences that may allow us in the future to design a larger study.
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation is the lead sponsor of 22 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Cognitively unimpaired subjects
Explicit participant agreement to undergo all the study procedures, which encompass:
Exclusion Criteria:
Cognitively unimpaired 18-25 years old
Other: No intervention
Cognitively unimpaired \>= 70 years old
Other: No intervention
No intervention
Concentration of CCL2
Differences in the concentration of CCL2 between age groups
Time frame: at inclusion
Concentration of CCL11
Differences in the concentration of CCL11 between age groups
Time frame: at inclusion
Concentration of CCL19
Differences in the concentration of CCL19 between age groups
Time frame: at inclusion
Concentration of Haptoglobin
Differences in the concentration of Haptoglobin between age groups
Time frame: at inclusion
Concentration of B2-microglobulin
Differences in the concentration of B2-microglobulin between age groups
Time frame: at inclusion
Concentration of TIMP2
Differences in the concentration of TIMP2 between age groups
Time frame: at inclusion
Concentration of CSF2
Differences in the concentration of CSF22 between age groups
Time frame: at inclusion
Concentration of GDF11
Differences in the concentration of GDF11 between age groups
Time frame: at inclusion
Concentration of oxytoxin
Differences in the concentration of oxytoxin between age groups
Time frame: at inclusion
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation